about
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease.Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.Association between changes in visual evoked magnetic fields and non-motor features in Parkinson's disease.Active brain changes after initiating fingolimod therapy in multiple sclerosis patients using individual voxel-based analyses for diffusion tensor imaging.Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.A Japanese multicenter survey characterizing pain in Parkinson's disease.Silencing of FUS in the common marmoset (Callithrix jacchus) brain via stereotaxic injection of an adeno-associated virus encoding shRNA.Anhedonia and its correlation with clinical aspects in Parkinson's disease.FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization.Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.Rhinorrhea in Parkinson's disease: a consecutive multicenter study in Japan.Slowly progressive folate-deficiency myelopathy: report of a case.Detecting sub-second changes in brain activation patterns during interictal epileptic spike using simultaneous EEG-fMRI.An unbiased data-driven age-related structural brain parcellation for the identification of intrinsic brain volume changes over the adult lifespan.Default Mode Network Changes in Moyamoya Disease Before and After Bypass Surgery∼Preliminary Report∼.Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.Non-motor multiple system atrophy associated with sudden death: pathological observations of autonomic nuclei.Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathy.Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment.Effects of Gradient Coil Noise and Gradient Coil Replacement on the Reproducibility of Resting State Networks.Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI StudyAge-related impairment in Addenbrooke's cognitive examination revised scores in patients with amyotrophic lateral sclerosisClinical correlates of repetitive speech disorders in Parkinson's diseaseCorpus callosal involvement is correlated with cognitive impairment in multiple system atrophySubjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE studyRandomized, double-blind, multicenter trial of hydrogen water for Parkinson's diseaseAlterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System AtrophyChanges in white matter fiber density and morphology across the adult lifespan: A cross-sectional fixel-based analysisLongitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective StudyReorganization of brain networks and its association with general cognitive performance over the adult lifespanSemantic deficits in ALS related to right lingual/fusiform gyrus network involvement
P50
Q27315985-946CD587-6259-4FFA-A430-D59E8D2DE5BFQ30578395-A9887C18-FDDF-46E1-B7F4-7C37F2E545C9Q33803870-BFDCC219-CE45-4869-9886-5E3FB4B30429Q37507448-15FC02BF-368A-4C6C-85A5-41AE18932559Q39095704-F3C3BB64-FBB6-4171-B013-A3BE30C55406Q39357724-51E0EE09-3E58-4F76-A551-7CDCD87981B1Q39748753-DBD633E2-6E3F-41E4-A0C0-BADC063B3A80Q40070020-70A87689-297C-4C9D-83ED-271C682D1C58Q40477612-D56086C6-FC52-4DAC-94A9-BBC88D934008Q41950782-8745D96D-3708-48CB-8661-160EA06A3487Q42320237-3499D8EE-D99F-4F9A-B77D-9AA9E29D9C84Q43727627-CA2C396D-0F6D-43DB-803F-4D098F152EC7Q43813580-C5B9C5B0-87C1-48A4-B423-3EB77FCC9DC2Q47231037-BF28C558-43DA-410A-8D5B-2DEF2F64B518Q47335180-CEDF0B52-00E1-4BCB-B537-8D985EB36DD3Q47837014-B9F84FA3-A990-47AE-8B86-E4AAF85087AFQ47989105-81F1BE29-CFA2-4CC6-8789-347281361FDBQ48307392-C47221A9-2425-402B-9F58-CF6FA111DEF9Q48426145-289C63C6-A0BF-4755-8147-E5D1DD52D092Q53072665-7394DA45-F0E8-4D4F-82E9-AEE950E43EB5Q55396464-6C836D86-95A0-4A17-BDC0-61D736E417A8Q57817897-44519F1D-F357-45BD-A182-F55E5A511B02Q58086182-6151FF27-AD79-4FCD-B961-68E0CAEB0EDDQ64767682-3BE933F2-640F-4A80-A98A-16A754DED3D3Q89424954-F81502C6-63A6-4615-B1AF-7A3ADCCD0462Q89586623-5FC50139-D9AE-43E2-84A0-2BF115C6ECF3Q91401025-123FE980-64FD-4543-ABBE-EEC501A5CB0AQ91873022-38D25AED-01F3-4FF7-833A-57F785A5A26FQ92029343-8CA5068A-BEC8-45E3-B7E8-FABFA8F85205Q92300986-2A0020E4-EAC1-4EB6-B397-E45CF3E9840EQ92460691-D920D537-B7BE-4F85-9A9D-0E0103E124B4Q93159945-ADDB5D7F-A674-4A62-920D-4C63B27E72BF
P50
description
researcher (ORCID 0000-0001-8553-8536)
@en
name
H Watanabe
@en
type
label
H Watanabe
@en
prefLabel
H Watanabe
@en
P31
P496
0000-0001-8553-8536